American Peptide expands manufacturing capacity

20 June 2008 04:52  [Source: ICIS news]

SAN DIEGO (ICIS news)--American Peptide is expanding manufacturing capacity for peptide production at its San Diego, USA, facility and expects to come on stream with the new capacity in the first quarter of 2009, the company said late on Thursday.

"We are currently able to make anything from gram to kilogram scales, and now we will be going over and beyond to manufacture 15-30 kilogram batches of cGMP [current good manufacturing practices] peptides for APIs [active pharmaceutical ingredients]," Shawn Shirzadi, vice president, quality, American Peptide said at the 2008 Biotechnology Industry Organization (BIO) International Convention in San Diego, USA.

The company expected to add roughly 10,000 sq ft to its existing facility for an undisclosed investment amount. The expansion translated into roughly four or five clean room suites and two or three large-scale synthesis rooms.

Strong demand for APIs was driving the company's expansion.

"We anticipate that this market is going to grow, and we have to get ready for that. Peptides are growing very popular as ingredients in APIs, especially at this point due to the mapping of the human genome and due to their low-toxicity, or in some cases, non-toxicity," said Shirzadi.

American Peptide is growing at a robust rate of 20-30% per annum, much higher than the API market's growth rate, which was last pegged at 10-15% last year.

In its latest step to promote a collaborative drug discovery and development engine in pharmaceuticals and life sciences, the company launched its new Total Peptide Management programme in April.

The programme is the first of its kind to offer a broad portfolio of peptides, value-added services, and expert consultation to support customers. American Peptides' expertise lies in its ability to bring new and innovative drugs from R&D to commercialisation rapidly and cost effectively.

The programme particularly benefits SMEs (small and medium enterprises) by providing the resources needed to take their drugs from development to the approval point.

To discuss issues facing the chemical industry go to ICIS connect


By: Feliza Mirasol
+1 713 525 2653



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly